Senators Inquiry and Analyst Price Target Cuts Put Allstate Under Pressure
Allstate Corporation (ALL) is facing congressional scrutiny after U.S. Senators Elizabeth Warren and Josh Hawley requested detailed records regarding denied and unpaid insurance claims. Lawmakers asked the company for data on closed claims that resulted in zero payout, specific reasons for claim denials, and details on whether employee or adjuster compensation is tied to claim outcomes.
Wall Street analysts responded with a series of price target adjustments. HSBC upgraded Allstate to a Buy rating while lowering its price target to $266. Other major firms lowered their expectations as well, with Barclays reducing its target to $221, Citigroup bringing its target down to $215, and Mizuho trimming its target from $300 to $295. Shares of Allstate recently traded down 0.52% at $229.40.
Investors will be paying close attention to how Allstate responds to the Senate inquiry and whether legislative pressure leads to regulatory action or operational changes in how the company handles claim payouts and adjuster compensation incentives.
Key points
- Senators Warren and Hawley asked Allstate for data on unpaid claims, denial reasons, and adjuster incentive structures.
- HSBC upgraded Allstate to a Buy rating but trimmed its price target to $266.
- Barclays, Citigroup, and Mizuho all reduced their price targets for Allstate stock.
- Allstate stock traded at $229.40, down 0.52% for the day.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
Why are U.S. senators investigating Allstate?
Senators Elizabeth Warren and Josh Hawley requested information on closed claims with no payout, reasons for claim denials, and whether adjuster pay is linked to claim outcomes.
How have Wall Street analysts changed their ratings on Allstate?
HSBC upgraded Allstate to Buy while trimming its price target to $266. Barclays, Citigroup, and Mizuho also lowered their price targets on the company.
What is Allstate's current stock price?
Allstate Corporation (NYSE:ALL) stock was trading at $229.40, down 0.52% for the day.